Abstract
We have shown that the capacity of 25g whey preloads to slow gastric emptying and reduce postprandial glycaemia persists after 4 weeks regular exposure in patients with diet-controlled type 2 diabetes. This dietary strategy therefore appears feasible for larger clinical trials to evaluate beneficial effects on long-term glycaemic control. Registered with the Australian New Zealand Clinical Trials Registry: ACTRN12614000831684.
Keywords:
Fructosamine; Glycated haemoglobin; Scintigraphy; Whey.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.
Publication types
-
Randomized Controlled Trial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Australia
-
Blood Glucose / metabolism
-
Body Mass Index
-
Cross-Over Studies
-
Diabetes Mellitus, Type 2 / blood
-
Diabetes Mellitus, Type 2 / diet therapy*
-
Diabetes Mellitus, Type 2 / physiopathology
-
Dietary Proteins / pharmacology*
-
Dietary Proteins / therapeutic use*
-
Female
-
Gastric Emptying / drug effects*
-
Gastric Emptying / physiology
-
Humans
-
Hyperglycemia / blood
-
Hyperglycemia / diet therapy*
-
Hyperglycemia / physiopathology
-
Male
-
Middle Aged
-
Postprandial Period / physiology
-
Single-Blind Method
-
Time Factors
-
Treatment Outcome
-
Whey Proteins / pharmacology*
-
Whey Proteins / therapeutic use*
Substances
-
Blood Glucose
-
Dietary Proteins
-
Whey Proteins